当前位置:
X-MOL 学术
›
Br. J. Sports Med.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
ICON 2023: International Scientific Tendinopathy Symposium Consensus – the core outcome set for Achilles tendinopathy (COS-AT) using a systematic review and a Delphi study of professional participants and patients
British Journal of Sports Medicine ( IF 11.6 ) Pub Date : 2024-10-01 , DOI: 10.1136/bjsports-2024-108263 Robert-Jan de Vos 1 , Karin Gravare Silbernagel 2 , Peter Malliaras 3 , Tjerk Sleeswijk Visser 4, 5 , Hakan Alfredson 6 , Inge van den Akker-Scheek 7 , Mathijs van Ark 8 , Annelie Brorsson 9 , Ruth Chimenti 10 , Sean Docking 11 , Pernilla Eliasson 9 , Kenneth Farnqvist 12 , Zubair Haleem 13, 14 , Shawn L Hanlon 15 , Jean-Francois Kaux 16, 17 , Rebecca Samantha Kearney 18 , Paul D Kirwan 19, 20 , Kornelia Kulig 21 , Bhavesh Kumar 22 , Trevor Lewis 23 , Umile Giuseppe Longo 24 , Tun Hing Lui 25 , Nicola Maffulli 26 , Adrian James Mallows 27 , Lorenzo Masci 28 , Dennis McGonagle 29, 30 , Dylan Morrissey 31, 32 , Myles Calder Murphy 33, 34 , Richard Newsham-West 35 , Katarina Maria Nilsson-Helander 36 , Richard Norris 37, 38 , Francesco Oliva 39 , Seth O'Neill 40 , Koen Peers 41 , Ebonie Kendra Rio 42 , Igor Sancho 43 , Alex Scott 44 , Kayla D Seymore 2 , Sze-Ee Soh 45 , Patrick Vallance 46 , Jan A N Verhaar 1 , Arco C van der Vlist 1 , Adam Weir 47, 48 , Jennifer Ann Zellers 49 , Bill Vicenzino 50
British Journal of Sports Medicine ( IF 11.6 ) Pub Date : 2024-10-01 , DOI: 10.1136/bjsports-2024-108263 Robert-Jan de Vos 1 , Karin Gravare Silbernagel 2 , Peter Malliaras 3 , Tjerk Sleeswijk Visser 4, 5 , Hakan Alfredson 6 , Inge van den Akker-Scheek 7 , Mathijs van Ark 8 , Annelie Brorsson 9 , Ruth Chimenti 10 , Sean Docking 11 , Pernilla Eliasson 9 , Kenneth Farnqvist 12 , Zubair Haleem 13, 14 , Shawn L Hanlon 15 , Jean-Francois Kaux 16, 17 , Rebecca Samantha Kearney 18 , Paul D Kirwan 19, 20 , Kornelia Kulig 21 , Bhavesh Kumar 22 , Trevor Lewis 23 , Umile Giuseppe Longo 24 , Tun Hing Lui 25 , Nicola Maffulli 26 , Adrian James Mallows 27 , Lorenzo Masci 28 , Dennis McGonagle 29, 30 , Dylan Morrissey 31, 32 , Myles Calder Murphy 33, 34 , Richard Newsham-West 35 , Katarina Maria Nilsson-Helander 36 , Richard Norris 37, 38 , Francesco Oliva 39 , Seth O'Neill 40 , Koen Peers 41 , Ebonie Kendra Rio 42 , Igor Sancho 43 , Alex Scott 44 , Kayla D Seymore 2 , Sze-Ee Soh 45 , Patrick Vallance 46 , Jan A N Verhaar 1 , Arco C van der Vlist 1 , Adam Weir 47, 48 , Jennifer Ann Zellers 49 , Bill Vicenzino 50
Affiliation
To develop a core outcome set for Achilles tendinopathy (COS-AT) for use in clinical trials we performed a five-step process including (1) a systematic review of available outcome measurement instruments, (2) an online survey on truth and feasibility of the available measurement instruments, (3) an assessment of the methodological quality of the selected outcome measurement instruments, (4) an online survey on the outcome measurement instruments as COS and (5) a consensus in-person meeting. Both surveys were completed by healthcare professionals and patients. The Outcome Measures in Rheumatology guidelines with a 70% threshold for consensus were followed. We identified 233 different outcome measurement instruments from 307 included studies; 177 were mapped within the International Scientific Tendinopathy Symposium Consensus core domains. 31 participants (12 patients) completed the first online survey (response rate 94%). 22/177 (12%) outcome measurement instruments were deemed truthful and feasible and their measurement properties were evaluated. 29 participants (12 patients) completed the second online survey (response rate 88%) and three outcome measurement instruments were endorsed: the Victorian Institute of Sports Assessment-Achilles questionnaire, the single-leg heel rise test and evaluating pain after activity using a Visual Analogue Scale (VAS, 0–10). 12 participants (1 patient) attended the final consensus meeting, and 1 additional outcome measurement instrument was endorsed: evaluating pain during activity/loading using a VAS (0–10). It is recommended that the identified COS-AT will be used in future clinical trials evaluating the effectiveness of an intervention. This will facilitate comparing outcomes of intervention strategies, data pooling and further progression of knowledge about AT. As COS-AT is implemented, further evidence on measurement properties of included measures and new outcome measurement instruments should lead to its review and refinement.
中文翻译:
ICON 2023:国际肌腱病科学研讨会共识 – 使用系统评价和对专业参与者和患者的 Delphi 研究确定跟腱病 (COS-AT) 的核心结果
为了开发用于临床试验的跟腱病核心结局集 (COS-AT),我们执行了一个五步过程,包括 (1) 对可用结果测量工具的系统评价,(2) 对可用测量工具的真实性和可行性的在线调查,(3) 对所选结果测量工具的方法学质量的评估, (4) 对结果测量工具作为 COS 的在线调查,以及 (5) 共识面对面会议。这两项调查均由医疗保健专业人员和患者完成。遵循风湿病学指南结局测量,共识阈值为 70%。我们从 307 项纳入研究中确定了 233 种不同的结局测量工具;177 项被映射到国际科学肌腱病研讨会共识核心领域内。31 名参与者 (12 名患者) 完成了第一次在线调查 (回复率 94%)。22/177 (12%) 的结果测量工具被认为是真实可行的,并评估了它们的测量特性。29 名参与者(12 名患者)完成了第二次在线调查(回复率 88%),并认可了三种结果测量工具:维多利亚运动评估研究所-跟腱问卷、单腿足跟抬高测试和使用视觉模拟量表评估活动后疼痛(VAS,0-10)。12 名参与者 (1 名患者) 参加了最终共识会议,并认可了 1 种额外的结果测量工具:使用 VAS (0-10) 评估活动/负重期间的疼痛。建议将已确定的 COS-AT 用于未来评估干预有效性的临床试验。 这将有助于比较干预策略的结果、数据汇总和有关 AT 的知识的进一步进展。随着 COS-AT 的实施,关于所包含措施的测量特性和新的结果测量工具的进一步证据应导致其审查和完善。
更新日期:2024-10-01
中文翻译:
ICON 2023:国际肌腱病科学研讨会共识 – 使用系统评价和对专业参与者和患者的 Delphi 研究确定跟腱病 (COS-AT) 的核心结果
为了开发用于临床试验的跟腱病核心结局集 (COS-AT),我们执行了一个五步过程,包括 (1) 对可用结果测量工具的系统评价,(2) 对可用测量工具的真实性和可行性的在线调查,(3) 对所选结果测量工具的方法学质量的评估, (4) 对结果测量工具作为 COS 的在线调查,以及 (5) 共识面对面会议。这两项调查均由医疗保健专业人员和患者完成。遵循风湿病学指南结局测量,共识阈值为 70%。我们从 307 项纳入研究中确定了 233 种不同的结局测量工具;177 项被映射到国际科学肌腱病研讨会共识核心领域内。31 名参与者 (12 名患者) 完成了第一次在线调查 (回复率 94%)。22/177 (12%) 的结果测量工具被认为是真实可行的,并评估了它们的测量特性。29 名参与者(12 名患者)完成了第二次在线调查(回复率 88%),并认可了三种结果测量工具:维多利亚运动评估研究所-跟腱问卷、单腿足跟抬高测试和使用视觉模拟量表评估活动后疼痛(VAS,0-10)。12 名参与者 (1 名患者) 参加了最终共识会议,并认可了 1 种额外的结果测量工具:使用 VAS (0-10) 评估活动/负重期间的疼痛。建议将已确定的 COS-AT 用于未来评估干预有效性的临床试验。 这将有助于比较干预策略的结果、数据汇总和有关 AT 的知识的进一步进展。随着 COS-AT 的实施,关于所包含措施的测量特性和新的结果测量工具的进一步证据应导致其审查和完善。